Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

FEMY

Femasys (FEMY)

Femasys Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FEMY
DateTimeSourceHeadlineSymbolCompany
18/04/202422:30GlobeNewswire Inc.Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare InitiativesNASDAQ:FEMYFemasys Inc
29/03/202407:05GlobeNewswire Inc.Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate UpdateNASDAQ:FEMYFemasys Inc
22/03/202400:00GlobeNewswire Inc.Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment LandscapeNASDAQ:FEMYFemasys Inc
20/03/202423:15GlobeNewswire Inc.Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of InfertilityNASDAQ:FEMYFemasys Inc
14/03/202400:00GlobeNewswire Inc.Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024NASDAQ:FEMYFemasys Inc
07/03/202401:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
07/03/202401:00GlobeNewswire Inc.Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility SolutionNASDAQ:FEMYFemasys Inc
29/02/202401:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
14/02/202413:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
14/02/202413:44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
07/02/202400:47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
03/02/202408:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
03/02/202408:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
03/02/202408:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
11/12/202316:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FEMYFemasys Inc
09/12/202301:28Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FEMYFemasys Inc
01/12/202309:17Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FEMYFemasys Inc
30/11/202308:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
23/11/202308:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
23/11/202308:33Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
23/11/202308:12Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:FEMYFemasys Inc
22/11/202309:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
16/11/202309:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
16/11/202300:30Business WirePharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.NASDAQ:FEMYFemasys Inc
02/11/202312:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FEMYFemasys Inc
11/10/202323:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
04/10/202300:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
04/10/202300:27Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FEMYFemasys Inc
27/09/202322:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
07/09/202307:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FEMYFemasys Inc
 Showing the most relevant articles for your search:NASDAQ:FEMY